These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 17651454)
1. Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer. Li X; Cao X; Li X; Zhang W; Feng Y Cancer Sci; 2007 Oct; 98(10):1592-6. PubMed ID: 17651454 [TBL] [Abstract][Full Text] [Related]
2. Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology. Bello DM; Russell C; McCullough D; Tierno M; Morrow M Ann Surg Oncol; 2018 Oct; 25(10):2884-2889. PubMed ID: 29968028 [TBL] [Abstract][Full Text] [Related]
3. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) in axillary drainage after operations for breast cancer using reverse transcriptase-polymerase chain reaction. Greenberg R; Schwartz I; Skornick Y; Kaplan O Breast Cancer Res; 2003; 5(3):R71-6. PubMed ID: 12793903 [TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of LRP16 gene in human breast cancer]. Liao DX; Han WD; Zhao YL; Pu YD; Mu YM; Luo CH; Li XH Ai Zheng; 2006 Jul; 25(7):866-70. PubMed ID: 16831279 [TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases]. Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002 [TBL] [Abstract][Full Text] [Related]
6. The Loss of Lymph Node Metastases After Neoadjuvant Chemotherapy in Patients With Cytology-proven Axillary Node-positive Primary Breast Cancer. Namura M; Tsunoda H; Kobayashi D; Enokido K; Yoshida A; Watanabe T; Suzuki K; Nakamura S; Yamauchi H; Hayashi N Clin Breast Cancer; 2019 Aug; 19(4):278-285. PubMed ID: 30975473 [TBL] [Abstract][Full Text] [Related]
7. Correlation between the DNA methylation and gene expression of IGFBP5 in breast cancer. Karabulut S; Kaya Z; Amuran GG; Peker I; Özmen T; Gūllūoḡlu BM; Kaya H; Erzik C; Ōzer A; Akkiprik M Breast Dis; 2016; 36(4):123-131. PubMed ID: 27612043 [TBL] [Abstract][Full Text] [Related]
8. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis. Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349 [TBL] [Abstract][Full Text] [Related]
9. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital. Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341 [TBL] [Abstract][Full Text] [Related]
10. Tumor-associated overexpression of the soluble T1-S receptor in lymph node-negative breast cancer. Werenskiold AK; Prechtel D; Harbeck N; Höfler H Diagn Mol Pathol; 2000 Mar; 9(1):26-34. PubMed ID: 10718210 [TBL] [Abstract][Full Text] [Related]
11. Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer. Cascione L; Gasparini P; Lovat F; Carasi S; Pulvirenti A; Ferro A; Alder H; He G; Vecchione A; Croce CM; Shapiro CL; Huebner K PLoS One; 2013; 8(2):e55910. PubMed ID: 23405235 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients. He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408 [TBL] [Abstract][Full Text] [Related]
13. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628 [TBL] [Abstract][Full Text] [Related]
14. Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue. Orlando C; Raggi CC; Bianchi S; Distante V; Simi L; Vezzosi V; Gelmini S; Pinzani P; Smith MC; Buonamano A; Lazzeri E; Pazzagli M; Cataliotti L; Maggi M; Serio M Endocr Relat Cancer; 2004 Jun; 11(2):323-32. PubMed ID: 15163307 [TBL] [Abstract][Full Text] [Related]
15. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor. Suzuki S; Takagi K; Miki Y; Onodera Y; Akahira J; Ebata A; Ishida T; Watanabe M; Sasano H; Suzuki T Cancer Sci; 2012 Jan; 103(1):136-43. PubMed ID: 21988594 [TBL] [Abstract][Full Text] [Related]
16. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351 [TBL] [Abstract][Full Text] [Related]
17. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand. Shahi KS; Bhandari G; Singh A J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737 [TBL] [Abstract][Full Text] [Related]
18. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis. Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532 [TBL] [Abstract][Full Text] [Related]
19. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast. Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma. Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]